May 2026
1. TENTORI L, Leonetti C, Muzi A, Dorio AS, et al
   [Corrigendum] Influence of MLH1 on colon cancer sensitivity to poly(ADP?ribose) polymerase inhibitor combined with irinotecan.
   Int J Oncol. 2026;68:55.
   

   >> Share

   
   
2. WU S, Wu F, Li X, Jiang Z, et al
   Smoking promotes colorectal cancer via the CKAP2L/AREG axis.
   Int J Oncol. 2026;68:59.
   

   >> Share

   
   April 2026
3. LIN H, Feng J, Chen P, Hu J, et al
   lncRNA AL445238.2?USP4 axis regulates cell survival and stemness in colon cancer.
   Int J Oncol. 2026;68:45.
   

   >> Share

   
   February 2026
4. XIONG B, Ma L, Hu X, Zhang C, et al
   [Retracted] Characterization of side population cells isolated from the colon cancer cell line SW480.
   Int J Oncol. 2026;68:22.
   

   >> Share

   
   January 2026
5. SUN H, Pan Y, He B, Deng Q, et al
   [Expression of Concern] Gene therapy for human colorectal cancer cell lines with recombinant adenovirus 5 based on loss of the insulin?like growth factor 2 imprinting.
   Int J Oncol. 2026;68:7.
   

   >> Share

   
   December 2025
6. FU D, Fu H, Wang Y, Yang K, et al
   Therapeutic potentials of plant?based antioxidants on colorectal cancer: Challenges and perspectives (Review).
   Int J Oncol. 2025;67:107.
   

   >> Share

   
   November 2025
7. COSTABILE V, Duraturo F, Delrio P, Rega D, et al
   [Corrigendum] Lithium chloride induces mesenchymal?to?epithelial reverting transition in primary colon cancer cell cultures.
   Int J Oncol. 2025;67:94.
   

   >> Share

   
   August 2025
8. PAN S, Deng Y, Fu J, Zhang Y, et al
   [Retracted] N6?methyladenosine upregulates miR?181d?5p in exosomes derived from cancer?associated fibroblasts to inhibit 5?FU sensitivity by targeting NCALD in colorectal cancer.
   Int J Oncol. 2025;67:62.
   

   >> Share

   
   March 2025
9. TAN S, Li S, Xia L, Jiang X, et al
   Long non?coding RNA ABHD11?AS1 inhibits colorectal cancer progression through interacting with EGFR to suppress the EGFR/ERK signaling pathway.
   Int J Oncol. 2025;66:20.
   

   >> Share

   
   
10. YANG Z, Chen Y, Wei X, Wu D, et al
    [Corrigendum] Upregulated NTF4 in colorectal cancer promotes tumor development via regulating autophagy.
    Int J Oncol. 2025;66:19.
    

    >> Share

    
    
11. JIN Z, Li Y, Yi H, Wang M, et al
    Pathogenetic development, diagnosis and clinical therapeutic approaches for liver metastasis from colorectal cancer (Review).
    Int J Oncol. 2025;66:22.
    

    >> Share

    
    
12. LI Z, Deng L, Cheng M, Ye X, et al
    Emerging role of bile acids in colorectal liver metastasis: From molecular mechanism to clinical significance (Review).
    Int J Oncol. 2025;66:24.
    

    >> Share

    
    February 2025
13. ZHANG Y, Wang J, Quan R, Lyu L, et al
    circ_0004662 contributes to colorectal cancer progression by interacting with hnRNPM.
    Int J Oncol. 2025;66:14.
    

    >> Share

    
    January 2025
14. PATLOLLA JMR, Zhang Y, Li Q, Steele VE, et al
    [Corrigendum] Anti?carcinogenic properties of omeprazole against human colon cancer cells and azoxymethane?induced colonic aberrant crypt foci formation in rats.
    Int J Oncol. 2025;66:3.
    

    >> Share

    
    December 2024
15. NAKANO Y, Masuda T, Sakamoto T, Tanaka N, et al
    SHARPIN is a novel gene of colorectal cancer that promotes tumor growth potentially via inhibition of p53 expression.
    Int J Oncol. 2024;65:113.
    

    >> Share

    
    October 2024
16. LI H, Li D, Meng N
    [Retracted] Effects of RUNX3 mediated Notch signaling pathway on biological characteristics of colorectal cancer cells.
    Int J Oncol. 2024;65:91.
    

    >> Share

    
    
17. WU K, Wu QX, Yuan SX, Wang DX, et al
    [Corrigendum] The role of IGFBP?5 in mediating the anti?proliferation effect of tetrandrine in human colon cancer cells.
    Int J Oncol. 2024;65:93.
    

    >> Share

    
    
18. TONG G, Shen Y, Li H, Qian H, et al
    NLRC4, inflammation and colorectal cancer (Review).
    Int J Oncol. 2024;65:99.
    

    >> Share

    
    September 2024
19. ZENG W, Liu H, Mao Y, Jiang S, et al
    Myeloid?derived suppressor cells: Key immunosuppressive regulators and therapeutic targets in colorectal cancer (Review).
    Int J Oncol. 2024;65:85.
    

    >> Share

    
    June 2024
20. KIM BR, Kim DY, Tran NL, Kim BG, et al
    Daunorubicin induces GLI1?dependent apoptosis in colorectal cancer cell lines.
    Int J Oncol. 2024;64:66.
    

    >> Share

    
    April 2024
21. KAKAFIKA MG, Lyta AA, Gavriilidis GI, Tsiftsoglou SA, et al
    Targeting mitochondrial bioenergetics by combination treatment with imatinib and dichloroacetate in human erythroleukemic K?562 and colorectal HCT?116 cancer cells.
    Int J Oncol. 2024;64:42.
    

    >> Share

    
    
22. SUN J, Chen S, Zang D, Sun H, et al
    Butyrate as a promising therapeutic target in cancer: From pathogenesis to clinic (Review).
    Int J Oncol. 2024;64:44.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share